LittleTechGirl on MSN
The AI cell counter that lives in the biosafety cabinet
Modern biology runs on precision, yet so much of the daily lab workflow remains stubbornly manual. Even today, one of ...
A UCR study finds just 6% of clinical trials used to approve new drugs in the U.S. reflect the country’s racial and ethnic ...
TB-500's Role in Biotech R&D Growth SHERIDAN, WY / ACCESS Newswire / December 12, 2025 / From 2024 to 2027, biotech R&D growth is increasingly shaped by a quiet enabler: high-purity ...
Information on admissions, scholarships, new courses, research studies and other events at schools and colleges ...
The sun rises over lush farm fields of on the outskirts of Lagos. For more than 20 years, a farmer named Joe has tilled the land, coaxing life from the earth and reaping bountiful harvests. But here, ...
News-Medical.Net on MSN
Most clinical trials fail to reflect America’s racial and ethnic diversity
A new study finds just 6% of clinical trials used to approve new drugs in the U.S. reflect the country's racial and ethnic makeup, with an increasing trend of trials underrepresenting Black and ...
Morning Overview on MSN
Study hints gray hair evolved as a cancer defense
For generations, gray hair has been treated as a cosmetic problem to hide, a visible marker of age and stress. Now a wave of ...
A new study finds just 6% of clinical trials used to approve new drugs in the U.S. reflect the country's racial and ethnic makeup, with an increasing ...
Interesting Engineering on MSN
World’s 2nd-fastest supercomputer trains first-ever nuclear-specific AI for reactors
Tech startup Atomic Canyon has harnessed the power of the Frontier supercomputer to train the first nuclear-specific ...
Scientists just brought us one step closer to the dream of unlimited power. On November 17 at the Nevada National Security Site, a nuclear energy startup called Valar Atomics achieved zero-power ...
Drug delivery is no longer just about convenience. It’s about enabling the therapies of the future to succeed where they ...
Final Decision from European Commission Expected in Q1 2026SOUTH SAN FRANCISCO, Calif., (GLOBE NEWSWIRE) -- Cytokinetics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results